| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | Solventum Corporation Common | Mar 27, 2026 | |
| Sell | Solventum Corporation Common | Dec 31, 2025 | |
| Buy | SOLVENTUM CORPORATION CMN | Nov 19, 2025 | |
| Sell | Solventum Corporation | Feb 6, 2025 | |
| Sell | Solventum Corporation Common | Jan 15, 2025 | |
| Buy | SOLVENTUM CORPORATION CMN | Nov 15, 2024 | |
| Sell | Solventum Corp | Jul 8, 2024 | |
| Sell | Solventum Corporation | May 14, 2024 | |
| Buy | Solventum Corporation Common | May 3, 2024 | |
| Sell | Solventum Corporation Common | May 3, 2024 |
This page tracks congressional stock trading activity in Solventum Corporation (SOLV) in the Healthcare sector. Disclosed Capitol has indexed 10 disclosed congressional trades involving SOLV. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of August 2026 — Disclosed Capitol has tracked 10 disclosed congressional trades in Solventum Corporation (SOLV) — 5:2 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Dec 31, 2025 | James French Hill | R | Sale | $15,001 - $50,000 |
| Nov 19, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Feb 6, 2025 | Ron L Wyden | D | Sale | $1,001 - $15,000 |
| Jan 15, 2025 | Julie Johnson | D | Sale | $1,001 - $15,000 |
| Nov 15, 2024 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jul 8, 2024 | Chuck Fleischmann | R | Sale | $1,001 - $15,000 |
| May 14, 2024 | Gary C Peters | D | Sale | $1,001 - $15,000 |
| May 3, 2024 | Thomas H Tuberville | R | Buy | $1,001 - $15,000 |
| May 3, 2024 | Thomas H Tuberville | R | Sell | $1,001 - $15,000 |
Across the 10 disclosed congressional trades in Solventum Corporation (SOLV), members of Congress have reported 2 buys and 5 sells. The average 30-day alpha vs. the S&P 500 is -0.27%.
As of July 2026, Solventum Corporation has 79 federal contract award records on file from USAspending.gov — most recently $2.2M from the Department of Health and Human Services on 2026-07-29.
| Award date | Agency | Amount |
|---|---|---|
| 2026-07-29 | Department of Health and Human Services · Centers for Medicare and Medicaid Services | $2.2M |
| 2026-07-29 | Department of Health and Human Services · Centers for Medicare and Medicaid Services | $2.2M |
| 2026-05-23 | Department of Veterans Affairs | $1.3M |
| 2026-05-21 | Department of Veterans Affairs | $1.3M |
| 2026-04-30 | Department of Veterans Affairs | -$7.5M |
| 2026-03-17 | Department of Defense · Defense Health Agency | $620K |
| 2026-01-13 | Department of Health and Human Services · National Institutes of Health | $188K |
| 2025-12-19 | Department of Veterans Affairs | $12.0M |
| 2025-12-18 | Department of Veterans Affairs | $12.0M |
| 2025-12-05 | Department of Defense · Defense Health Agency | $422K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Solventum Corporation reported revenue of $8.32B and net income of $1.56B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $2.21B, net income $92.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.